in the absence of a submission from the holder of the marketing authorisation:
pitolisant (Wakix®) is not recommended for use within NHS Scotland.
Indication under review: Treatment of narcolepsy with or without cataplexy in adults
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
|Drug Name:||pitolisant (Wakix)|
|SMC Drug ID:||1229/17|
|Manufacturer:||Lincoln Medical Limited|
|Indication:||for the treatment of narcolepsy with or without cataplexy in adults.|
|Sub Category:||4.5 Drugs used in the treatment of obesity|
|Submission Type:||Non submission|
|Date Advice Published:||13 February 2017|